Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 1,673 Shares

What Happened
Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), sold 1,673 shares on September 2, 2026, in an open-market/private sale for a weighted-average price of $19.66 per share, generating proceeds of approximately $32,885. This was a sale (not a purchase) and was executed to satisfy tax-withholding obligations related to vested restricted stock units.

Key Details

• Transaction date: 2026-09-02; Form 4 filed: 2026-09-03 (timely filing).
• Sale type/code: S (open market or private sale).
• Shares sold: 1,673; weighted-average price: $19.66; total proceeds ≈ $32,885.
• Price range: $19.60–$19.74 across multiple transactions; the filing reports the weighted-average price (footnote F2).
• Reason: Sold to satisfy tax withholding on RSUs vested Feb 25, 2025 (footnote F1).
• Shares owned after transaction: not specified in this filing.
• Filing timeliness: appears timely (filed the business day after the transaction).

Context
This sale was a tax-withholding / cashless-type disposition tied to RSU vesting and is a routine administrative transaction rather than a straightforward vote of confidence or concern. Sales for tax withholding are common and do not necessarily indicate the insider’s view on the company’s prospects.